Aflac Incorporated

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Aflac’s (AFL) Net Earnings Jumped 37.7%, Yet Adjusted Earnings Actually Fell

Dividend Earnings report AI-generated analysis

πŸ“‰ Adjusted earnings fell 7.7% to $883 million in the second quarter, contrasting with a 37.7% jump in net earnings driven by lower investment losses.

πŸ’± A weaker yen averaging 159.45 to the dollar reduced adjusted earnings by $0.05 per share, masking underlying operational improvements.

πŸ‡―πŸ‡΅ Japan's pretax adjusted margin widened to 34.3% as claims took a smaller bite out of premiums, though yen-based earnings still declined 2.1%.

πŸ“ˆ US net earned premiums rose 2.3% to $1.5 billion and sales climbed 2.6% to $349 million, led by group voluntary benefits and dental plans.

πŸ’° The company returned $1.3 billion to shareholders in the quarter through buybacks and a declared third-quarter dividend of $0.61 per share.

πŸ“‰ US pretax adjusted earnings fell 4.6% to $370 million as margins narrowed to 20.9% due to higher claims and benefits costs.

πŸ“‰ Japan's net earned premiums in yen fell 3.7% primarily due to a new external reinsurance deal and older limited-pay policies reaching paid-up status.

πŸ“‰ Premium persistency in Japan slipped to 92.7% from 93.7%, indicating some customers are dropping policies.

πŸ“‰ New sales in Japan dipped 5.6% in the quarter, partly due to a tough comparison with the Miraito cancer product launched in March 2025.

🏦 Corporate and Other segments swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6%.

πŸ“‰ Adjusted book value per share slid to $41.22 at June 30 from $42.97 a year earlier when excluding foreign currency remeasurement.

πŸ“‰ Hedge fund holders of Aflac fell to 39 in the latest quarter from 46 in the prior one, suggesting institutions are trimming positions.

Bullish Signals
  • Net earnings jumped 37.7% to $825 million in the second quarter, driven by investment losses shrinking significantly from $421 million a year ago to $153 million.
  • Excluding currency effects, adjusted earnings per share rose 4.1% to $3.57, indicating underlying operational strength despite foreign exchange headwinds.
  • Japan's pretax adjusted margin widened to 34.3% from 32.0% as claims took a smaller bite out of premiums, improving profitability efficiency.
  • The US business achieved top-line growth with net earned premiums rising 2.3% to $1.5 billion and sales climbing 2.6% to $349 million.
  • Aflac returned $1.3 billion to shareholders in the quarter, including $983 million in buybacks and a declared third-quarter dividend of $0.61 per share.
  • Management notes 43 straight years of dividend increases through 2025 and says the board is on a path to extend that streak in 2026.
Risk Factors
  • Adjusted earnings fell 7.7% to $883 million, signaling a decline in core operational profitability despite higher net earnings.
  • A weaker yen averaging 159.45 to the dollar cost adjusted earnings $0.05 per share, negatively impacting reported financial performance.
  • Japan's net earned premiums in yen fell 3.7% due to a new external reinsurance deal and older limited-pay policies reaching paid-up status.
  • Premium persistency in Japan slipped to 92.7% from 93.7%, indicating that customers are keeping fewer policies than before.
  • US pretax adjusted earnings fell 4.6% to $370 million as margins narrowed to 20.9% due to claims and benefits taking a bigger share of premiums.
  • Corporate and Other segments swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6%.
  • New sales in Japan dipped 5.6% in the quarter against a tough comparison for the Miraito cancer product which launched in March 2025.
  • Adjusted book value per share slid to $41.22 at June 30 from $42.97 a year earlier when excluding foreign currency remeasurement.
  • Hedge fund holders of Aflac fell to 39 in the latest quarter from 46 in the prior one, suggesting institutions are trimming their positions.
Full Analysis
Aflac (NYSE: AFL) reported mixed second-quarter results on August 6, with net earnings jumping 37.7% to $825 million driven by a sharp reduction in investment losses from $421 million to $153 million. However, adjusted earnings fell 7.7% to $883 million, creating a divergence between reported profitability and core operational performance. The decline in adjusted earnings was primarily impacted by a weaker yen, which averaged 159.45 to the dollar, costing the company $0.05 per share. Excluding currency effects, adjusted earnings per share actually rose 4.1% to $3.57. In Japan, pretax adjusted margins widened to 34.3% as claims took a smaller bite out of premiums, though yen-based pretax adjusted earnings still fell 2.1% after stripping out the currency impact. The US business showed top-line growth with net earned premiums rising 2.3% to $1.5 billion and sales climbing 2.6% to $349 million, led by group voluntary benefits and dental/vision plans. Despite this revenue growth, pretax adjusted earnings in the US fell 4.6% to $370 million as margins narrowed to 20.9%. The company returned $1.3 billion to shareholders via buybacks and dividends, maintaining a streak of 43 consecutive years of dividend increases. Concerns remain regarding Japan's premium base, where net earned premiums fell 3.7% due to new reinsurance deals and older policies reaching paid-up status. Premium persistency slipped to 92.7%, and new sales dipped 5.6%. Additionally, the US segment faced higher claims and benefits costs, while corporate losses widened to $10 million. Hedge fund holdings decreased to 39, indicating some institutional trimming despite a low short interest of 2.84%.